Brookings Schaeffer Initiative for Health Policy
Our work in Brookings Schaeffer Initiative for Health Policy
-
Medicare Payment for Physician-Administered (Part B) Drugs: The Interim Final Rule and a Better Way Forward
A look at how policymakers can reform an interim-final rule to use Medicare’s demonstration authority under the Center for Medicare and Medicaid Innovation (CMMI) to make large reductions in the amounts it pays physicians for high-cost medicines they administer under Part B.
-
Understanding the No Surprises Act
A look at the No Surprise Act, a new federal law that ends surprise out-of-network billing. The law was passed late last year as part of the omnibus bill.
-
Expanded Coverage for COVID-19 Testing Must Include Limits On Costs
Schaeffer Initiative experts discuss why the most efficient and equitable way to conduct testing on a mass scale for COVID-19 is through a federally-funded public effort that tests everyone, but until Congress enacts such a program, mandating insurance coverage is an important lever to improve access to testing.
-
Reaching Agreement on COVID-19 Immunity “Passports” Will Be Difficult
Vaccine privileges would allow those who can show immunity to COVID-19 access to certain high-risk activities. USC-Brookings Schaeffer Initiative for Health Policy conducted a survey to understand the general public’s views on the topics.
-
Paying for Cell and Gene Therapies in Medicare
Join Schaeffer Center Director Dana Goldman in conversation with Jeet Guram and Kathy Buto about policy lessons learned and potential solutions to support innovation and patient access in cell and gene therapies.
Categorized in -
How Can the Biden Administration Improve the Medicaid Program?
The panel will examine options to improve Medicaid eligibility rules, enrollment processes, and benefit designs, as well as approaches that could improve the quality and efficiency of the care delivered to Medicaid beneficiaries.
Categorized in -
Universal Vaccine Adoption Will Require Coordinated, Creative Strategy Say Experts at USC Schaeffer Event
According to a survey of Americans conducted in December, only 63% of individuals surveyed said they would take the COVID-19 vaccine, down from 83% in March. Schaeffer Center hosted an expert webinar on strategies to increase vaccine adoption.
Categorized in -
Arbitration Over Out-Of-Network Medical Bills: Evidence From New Jersey Payment Disputes
Arbitrators seemed to anchor decision around surprising billing to the 80th percentile of charges with the median decision being 5.7 times prevailing in-network rates for the same services.
-
Arbitration Decisions in New Jersey Surprise Billing Cases Result in Large Payouts
The mean award was 9 times higher than the median in-network price for the same services.
-
How to Encourage Vaccine Adoption
How can public health leaders address vaccine hesitancy? Join the USC-Brookings Schaeffer Initiative for Health Policy and the USC Behavioral Science and Well-Being Policy Initiative for an expert discussion on vaccine adoption.
Categorized in